Home - Products - Others - Other Targets - Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)

Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)

CAS No. 9004-32-4

Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)( CMC-Na (Viscosity:800-1200 mPa.s) )

Catalog No. M22463 CAS No. 9004-32-4

Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 30 In Stock
1G 41 In Stock

Biological Information

  • Product Name
    Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.
  • Description
    Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CMC-Na (Viscosity:800-1200 mPa.s)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    9004-32-4
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Du XH, et al. Dexamethasone and sodium carboxymethyl cellulose prevent postoperative intraperitoneal adhesions in rats. Braz J Med Biol Res. 2015 Apr;48(4):344-8.
molnova catalog
related products
  • Oxyberberine

    Oxyberberine is isolated from the methanol extract of A. mexicana. It has been used to study the SW480 human colon cancer cell line.

  • BRD-K98645985

    BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC50 of ~2.37 μM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity.

  • Lyoniside

    Lyoniside and saracoside are cytotoxic to promastigotes and intracellular amastigotes, they demonstrate strong anti-leishmanial efficacies in BALB/c mice model of leishmaniasis, suggests that these two compounds potential anti-leishmanial candidates.